![Robert Wild](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Wild
Consultant / Adviseur bij
ShangPharma Innovation, Inc.
Profiel
Robert Wild was the founder of Dracen Pharmaceuticals, Inc., founded in 2017, where the title held was Chief Scientific Officer & Founding Executive from 2017 to 2023.
Dr. Wild currently holds the position of Executive In Residence at ShangPharma Innovation, Inc. since 2017.
Former jobs include Co-Chief Executive Officer at Azkarra Therapeutics, Inc., Senior Director & Head at OSI Pharmaceuticals, Inc. from 2006 to 2010, Chief Scientific Officer at Eli Lilly & Co., and Chief Scientific Officer & Senior VP-Research at Ignyta, Inc. from 2014 to 2016.
Education includes undergraduate and doctorate degrees from the University of Minnesota, conferred in 1995 and 2000 respectively.
Actieve functies van Robert Wild
| Bedrijven | Functie | Begin |
|---|---|---|
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Consultant / Adviseur | 01-03-2017 |
Eerdere bekende functies van Robert Wild
| Bedrijven | Functie | Einde |
|---|---|---|
Azkarra Therapeutics, Inc.
 Azkarra Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies | Algemeen Directeur | 01-03-2025 |
Dracen Pharmaceuticals, Inc.
 Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Oprichter | 01-02-2023 |
| IGNYTA INC | Hoofd Techniek/Wetenschap/O&O | 22-02-2016 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-08-2010 |
| ELI LILLY AND COMPANY | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Robert Wild
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
96
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Finance |
Dracen Pharmaceuticals, Inc.
Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Azkarra Therapeutics, Inc.
Azkarra Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies | Health Technology |
